Characteristics of B-cell lymphomas in HIV/HCV-coinfected patients during the combined antiretroviral therapy era: An ANRS CO16 LYMPHOVIR cohort study

Journal of Acquired Immune Deficiency Syndromes

Volumn 63, Issue 2, 2013, Pages 249-253

  Terrier, Benjamin ^a   Costagliola, Dominique ^a,b   Prevot, Sophie ^c,d   Chavez, Houria ^b,e   Missy, Pascale ^a,b   Rince, Patricia ^d,e   Costello, Regis ^f   Escaut, Lelia ^e   Gabarre, Jean ^g   Joly, Bertrand ^h   Letranchant, Lorraine ⁱ   Le Gouill, Steven ^j   Morineau Le Houssine, Pascale ^j   Simon, Anne ^a   Canioni, Danielle ^k   Hermine, Olivier ^k   Cacoub, Patrice ^a   Taoufik, Yassine ^b,d,e   Raphael, Martine ^d,e,l   Besson, Caroline ^b,d,e  

^a SORBONNE UNIVERSITÉ   (France)

^b INSERM   (France)

^c HÔPITAL ANTOINE BÉCLÈRE   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^f Department of Hematology   (France)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^h CENTRE HOSPITALIER SUD FRANCILIEN   (France)

ⁱ UNIVERSITY HOSPITAL OF NANCY   (France)

^j NANTES UNIVERSITY HOSPITAL   (France)

^k HÔPITAL NECKER ENFANTS MALADES   (France)

^l UMR 8126   (France)

more..

Author keywords

Antiviral therapy; HCV infection; HIV infection; Lymphoplasmacytic lymphoma; Marginal zone lymphoma; Non Hodgkin lymphoma

Indexed keywords

ANTIRETROVIRUS AGENT; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; PEGINTERFERON ALPHA; PREDNISONE; RIBAVIRIN; RITUXIMAB; VINCRISTINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; VIRUS ANTIBODY;

ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CARCINOGENESIS; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; COHORT ANALYSIS; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LARGE CELL LYMPHOMA; MALE; MARGINAL ZONE LYMPHOMA; MIXED INFECTION; MULTICENTER STUDY; PLASMABLASTIC LYMPHOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPLENIC MARGINAL ZONE LYMPHOMA; STIMULATION; VIRUS LOAD; WALDENSTROEM MACROGLOBULINEMIA; BLOOD; HEPATITIS C VIRUS; IMMUNOLOGY; MIDDLE AGED; VIROLOGY;

ADULT; AGED; ANTI-HIV AGENTS; ANTIBODIES, VIRAL; COHORT STUDIES; COINFECTION; FEMALE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HUMANS; LYMPHOMA, AIDS-RELATED; LYMPHOMA, B-CELL; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VIRAL LOAD;

MLCS; MLOWN;

EID: 84879740347     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31828a77f0     Document Type: Article

References (19)

1. Carbone A, Cesarman E, Spina M, et al. HIV-associated lymphomas and gamma-herpesviruses. Blood. 2009;113:1213-1224.
2. Guiguet M, Boue F, Cadranel J, et al. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. Lancet Oncol. 2009;10:1152-1159.
3. Besson C, Goubar A, Gabarre J, et al. Changes in AIDS-related lym-phoma since the era of highly active antiretroviral therapy. Blood. 2001; 98:2339-2344.
4. Bonnet F, Burty C, Lewden C, et al. Changes in cancer mortality among HIV-infected patients: the Mortalite 2005 Survey. Clin Infect Dis. 2009; 48:633-639.
5. Marcucci F, Mele A. Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities. Blood. 2011;117:1792-1798.
6. Besson C, Canioni D, Lepage E, et al. Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs. J Clin Oncol. 2006;24:953-960.
7. Hermine O, Lefrere F, Bronowicki JP, et al. Regression of splenic lym-phoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med. 2002;347:89-94.
8. Jaffe ES. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology Am Soc Hematol Educ Program. 2009:523-531.
9. Girard T, Luquet-Besson I, Baran-Marszak F, et al. HIV+ MALT lym-phoma remission induced by highly active antiretroviral therapy alone. Eur J Haematol. 2005;74:70-72.
10. Boulanger E, Meignin V, Baia M, et al. Mucosa-associated lymphoid tissue lymphoma in patients with human immunodeficiency virus infection. Br J Haematol. 2008;140:470-474.
11. Raphael M, Said J, Borish B, et al, eds. Lymphomas Associated With HIV Infection. Lyon, France: IARC press; 2008.
12. Cortot AB, Cottin V, Issartel B, et al. Pulmonary MALT lymphoma revealing AIDS[in French]. Rev Mal Respir. 2006;23:353-357.
13. Cagliuso M, Conti V, Trasarti S, et al. Splenic marginal zone lym-phoma in a HIV-1 infected patient: evidence favouring a pathogenetic role of HIV-1 itself in the lymphomagenesis. Infection. 2013;41: 255-258.
14. Capello D, Martini M, Gloghini A, et al. Molecular analysis of immu-noglobulin variable genes in human immunodeficiency virus-related non-Hodgkin's lymphoma reveals implications for disease pathogenesis and histogenesis. Haematologica. 2008;93:1178-1185.
15. Besson C, Pialoux G, Dupont B, et al. Lack of association between HCV infection and HIV-related lymphoma. Br J Haematol. 1999;105: 568-569.
16. Day CL, Kaufmann DE, Kiepiela P, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature. 2006;443:350-354.
17. Moir S, Ho J, Malaspina A, et al. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exp Med. 2008;205:1797-1805.
18. Larsen C, Pialoux G, Salmon D, et al. Prevalence of hepatitis C and hepatitis B infection in the HIV-infected population of France, 2004. Euro Surveill. 2008;13:pii=18888. Available at: http://www.eurosurveillance. org/ViewArticle.aspx?ArticleId=18888. Accessed February 24, 2013.
19. Levine AM, Nelson R, Zuckerman E, et al. Lack of association between hepatitis C infection and development of AIDS-related lymphoma. J Acquir Immune Defic Syndr Hum Retrovirol. 1999;20:255-258.